.png){kind=icon}
.png){kind=icon}
Return
Granulomatous Dermatoses and Sarcoidosis/Sarcoid-Like Disease During Dupilumab Therapy: A Phenotype-Based Case-Level Review
.png){kind=icon}
OA
AI
M
G
DOI：10.1155/dth/2212248.png)
.png){kind=icon}
.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Dupilumab, an interleukin-4 receptor alpha antagonist, is widely used across Type 2 inflammatory diseases. Case reports have described granulomatous inflammation arising or worsening during treatment, but the reported phenotypes are scattered across dermatology, respiratory and allergy literature.
Keywords:
drug-induced sarcoidosis-like reaction
dupilumab
granulomatous dermatitis
sarcoidosis-like reaction
AI Summary
Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.
Journal
IF:
3.4
Papers:
4.8K
Citations:
7.1K
Organization
Cited Papers